CLINICAL CANCER RESEARCH
期刊信息导读
- CLINICAL CANCER RESEARCH基本信息
- CLINICAL CANCER RESEARCH中科院SCI期刊分区
- 历年CLINICAL CANCER RESEARCH影响因子趋势图
- CLINICAL CANCER RESEARCH期刊英文简介
- CLINICAL CANCER RESEARCH期刊中文简介
CLINICAL CANCER RESEARCH基本信息
简称:CLIN CANCER RES
中文名称:临床癌症研究
研究方向:医学
2018-2019最新影响因子:8.911
2022年6月28日更新影响因子:13.801
SCI类别:SCI/SCIE
是否OA开放访问:No
出版地:UNITED STATES
出版周期:Semimonthly
创刊年份:1995
年文章数:752
涉及的研究方向:医学-肿瘤学
通讯方式:AMER ASSOC CANCER RESEARCH, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404
官方网站:http://clincancerres.aacrjournals.org/
投稿网址:http://ccr.msubmit.net/cgi-bin/main.plex
审稿速度:平均2.1月
平均录用比例:约30%
PMC链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1078-0432%5BISSN%5D
CLINICAL CANCER RESEARCH期刊英文简介
Published by American Association for Cancer Research. ISSN: 1078-0432.Clinical Cancer Research publishes original articles describing clinical research on the cellular and molecular characterization, prevention, diagnosis, and therapy of human cancer. Its focus is on innovative clinical research and translational research which bridges the laboratory and the clinic. Clinical Cancer Research is especially interested in clinical trials evaluating new treatments for cancer; research on molecular abnormalities that predict incidence, response to therapy, and outcome, and laboratory studies of new drugs and biological agents that will lead to clinical trials in patients.
CLINICAL CANCER RESEARCH期刊中文简介
由美国癌症研究协会出版。ISSN: 1078 - 0432。临床癌症研究发表原创文章描述临床研究的细胞和分子特征,预防,诊断和治疗人类癌症。其重点是创新的临床研究和转化研究,连接实验室和临床。临床癌症研究对评估新的癌症治疗方法的临床试验特别感兴趣;研究预测发病率、对治疗的反应和结果的分子异常,以及新药物和生物制剂的实验室研究,这些将导致患者进行临床试验。
中科院SCI期刊分区:
CLINICAL CANCER RESEARCH影响因子
获取相关优质资源获取2023中科院分区